disclaim financi forecast recommend current review
conduct analyst
govern code ethics/cod conduct
polici secur trade polici
equival invest research
interest visit
primari analyst cover compani
stock
research sep
estim aug
price data sep
rate updat sep
currenc amount express
busi strategi outlook
methodolog valu compani
busi strategi outlook
believ manag invest strategi
instrument form narrow-moat enterpris deploy
capit intern initi acquisit fortifi firm
posit global leader infect prevent
purchas isomedix form foundat upon
compani built lead posit contract steril servic
healthcar industri cap acquisit -base
synergi health think piec busi
repres widest-moat segment firm switch cost
regulatori intang creat impedi custom
transit provid barrier dissuad
competit entri elsewher compani view
healthcar product life scienc busi convincingli
narrow-moat segment franchis sell steril
surgic suit biopharma
manufactur plant benefit embed switch
cost associ long-liv capit equip
product repair busi think manag abl
improv margin time rightsiz invest
continu consolid fragment industri
ultim think firm posit offer convinc
opportun earn return excess cost capit
come decad estim manag abl
consist earn midteen return invest capit
enterpris number mute recent year addit
synergi health cost integr begin fade
believ firm like return histor level econom
profit gener driven substanti margin improv
manag work prune busi portfolio divest
no-margin linen busi primari driver
expect near-term cost improv time anticip
firm abl sustain basi point annual
margin expans drive acceler forecast
valuat summari forecast
financi summari forecast
historical/forecast data sourc morningstar estim may reflect adjust
 -base medic devic compani focus steril
servic infect prevent compani global leader
contract steril servic ensur safe deliveri single-us
implant medic equip hospit around world addit
sell steril washer-disinfector decontamin
equip suppli use care provid facil biopharma
manufactur site domicil unit state
invers firm continu deriv roughli revenu
oper unit kingdom remain
intern region
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
place review evalu long-
term coverag decis provid broad coverag
compani global period adjust
coverag accord investor interest staf
rais fair valu estim per share
updat model recent result take
account cash flow firm receiv sinc
last updat impli roughli time
estim fiscal adjust earn ebitda
respect report revenu growth came
ahead expect forecast organ revenu
growth averag roughli forecast period
think earn sustain grow low-double-digit
rang time revenu growth margin improv
accret acquisit help bolster firm bottom
line expect gross margin improv roughli
basi point come five year adjust
outsiz oper leverag driven reduct one-off
cost associ integr effort partial off-set
modest acceler research develop activ
ultim think culmin termin
oper margin roughli net margin
approxim metric somewhat
higher firm earn normal basi
histor support improv revenu mix
post-synergi acquisit given expans
given steadi growth cash flow give steri
bull-cas scenario forecast organ revenu
growth roughli basi point ahead base case
five-year forecast period given healthi margin
expans forecast base-cas scenario bull
case incorpor modest upsid base-cas
expect result oper margin
net margin predict fall final
year model assumpt result fair valu
estim per share time time
bull-cas forecast fiscal adjust earn
meaning recent trend impli averag
growth rate forecast period closer
scenario expect price pressur acceler result
gross margin forecast roughli flat
result adjust oper margin declin
modestli throughout explicit forecast result
termin net margin approxim line
peak perform busi histor
bear-cas assumpt culmin fair valu estim
per share time lower forecast
adjust earn ebitda respect
develop narrow moat underpin
embed custom switch cost ultim view
appli steril technolog ast segment
moatiest aspect firm healthcar specialti
servic divis rel commodit two
segment healthcar product life scienc sell similar
technolog two separ end market
busi view deserv narrow moat rate
domin infect prevent posit
well continu provid key servic global
ast segment view one interest
aspect compani would probabl deserv wide
moat rate oper stand-alon entiti segment
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
true lack incent pursu price concess
area final custom three-
five-year contract busi show remark stabil
help gener cash manag abl invest
across compani acquisit synergi health
posit clear number one global contract
steril synergi intern busi complement
legaci number-two posit
benefit
healthcar product life scienc segment
steri
century-long tenur global infect prevent along
long-liv capit equip provid repeat
consum sale servic
requir
dissuad frequent replac stack
global leader steril servic product line
encompass steam hydrogen peroxid chemic
reprocess
endoscop surgic suppli seven-to ten-year
product live hospit set firm abl drive
signific lifetim custom valu one
system placement altern firm sale
biopharma end market encapsul custom
project order conjunct expans
manufactur capac vaccin biolog
order rang hundr thousand
low-single-digit million dollar valu central
safe effici product product
environ regulatori intang also play
biopharma market fda-inspect manufactur site
must maintain complianc written product
procedur risk taken offlin
firm healthcar servic segment like no-moat
franchis predominantli instrument repair
busi maintain roughli one third
highli fragment market primari focu
repair endoscop surgic equip
low-margin labor-intens servic oper
ga treatment
one global busi focus
steril single-us implant medic suppli
deliveri use hospit surgic
set industrywid basi effect two
mechan suppli steril today
manag posit firm roughli equal
exposur two modal modest tilt toward
radiat segment revenu think
attract busi multitud reason -- high capit
util structur growth driver duopoli structur
combin creat strong growth high margin ration
price addit extrem high cost failur
rel low contribut overal devic cost mean
product manufactur littl incent switch
vendor implant sutur needl caus
unnecessari infect potenti food drug
administration-mand recal brand impair
physician backlash would far outpac small price
benefit attain switch nascent competitor
steril cost less cost manufactur
incur product transport help illustr
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
think manag current invest right
area wed consid neg moat trend rate
fall behind
lead edg steril
technolog ast product busi
interest firm nascent presenc outsourc
steril depart hospit surgic center
preval intern market particularli
 rel new concept firm bring
take
manag on-site locat use in-hous
facil reprocess uniqu opportun
long runway growth pace chang
area like glacial expect consist
make inroad time
stabl moat trend rate dont forese
much strengthen weaken underli
switch cost moat sourc expect firm maintain
lead posit contract steril servic
expand lead tradit healthcar life
scienc market also anticip manag
return steadi pace privat tuck-in acquisit
synergi health fulli integr firm balanc
sheet return histor leverag level
like rout capit deploy continu roll
fragment devic repair servic industri
think add valu right price
unlik contribut expans firm moat given
segment no-moat characterist think
reason growth strategi pursu
wed normal expect biggest risk firm
moat brand impair due fda recal
qualiti breakdown lose custom trust way steri
handl fda recal platform give us
comfort manag abil navig crisi
confid quick approv replac platform
gener custom accommod allow overal
busi emerg fda consent decre rel
unscath compar compani find
regulatori scrutini addit
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
owith plan divestitur complet steri
better abl focu acceler organ growth
oth balanc sheet allow manag return
value-ad acquisit activ rather
alloc excess cash debt repay
posit benefit continu growth
healthcar util broadli rel
unaffect transit
inpati
compet area healthcar seen
fair share product recal costli
compani custom patient
weigh result longer initi expect
owith passag corpor tax reform
lose much financi advantag gain
invers
oth ast busi highli reliant abil
replenish suppli
long-term suppli contract place radioact
materi suppli hand compani
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
equival begin period
total avail debt servic
oblig commit
total oblig commit
adjust free
gener
gener revolv adjust
commit
manag prove prudent util
balanc sheet meet goal reduc debt associ
merger synergi health
estim firm took leverag level near time
adjust ebitda conjunct deal far beyond
premerg averag leverag posit littl
turn fiscal look like metric
retreat time reason
underleverag level narrow-moat enterpris
believ manag turn
capital-alloc
prioriti away debt reduct toward increas
invest potenti acquisit opportun
come year level financi flexibl enhanc
strong cash gener profil anticip
firm gener roughli million free cash flow
fiscal set grow midteen compound
annual growth rate fiscal
given firm predict driver revenu
equip sale believ warrant medium
uncertainti rate healthcar broadli continu
affect concern around excess price power steri
revenu base instead tie product volum
much stabl tend grow
mid-single-digit rang fairli consist whether
contract steril medic equip steril
consum sold surgic set servic
repair capit equip view larg
insul volatil seen elsewher
sector fact firm maintain presenc across
care set whether acute-car hospit
ambulatori surgeri center age popul
provid sustain growth tailwind regardless
patient receiv medic care factor combin
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
creat grow free cash flow stream manag
abl alloc among capit expenditur dividend
increas acquisit opportun
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
repres date owner name posit common share held report holder issuer
manag team togeth
decad demonstr substanti valu creation
intens focu return valu sharehold via
dividend warrant exemplari stewardship rate ceo
walter rosebrough skill shepherd compani
econom crisi sizabl product recal
feder trade commiss merger challeng
keep best interest sharehold mind
central assess execut remain
solid firm transit strategi heavili
focus acquisit last five year
manag team priorit return invest capit
pre-emin measur valu creation mesh
well intern valuat methodolog
manag continu reinvest busi
need expand capac refresh long-cycl
product think priorit acquisit
opportun sharehold return prudent given
limit need substanti invest firm core
franchis cash flow continu grow anticip
well see ever-grow dividend tuck-in bolt-on
acquisit primari use excess capit think
sourc valuat execut activ
time value-enhanc overal asid
contribut synergi health compani
abl earn consist midteen return capit
time includ goodwil contribut
annual deal think hallmark success
share
fund
share
fund
new york mellon corp
think firm pay structur adequ align
manag incent interest sharehold
execut offic variabl pay make
total annual compens major tie
equity-link structur like see annual
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
incent bonus paid base annual target
oper incom free cash flow two metric favor
easili adjust item ep wed like
see substanti insid ownership total
director offic cohort maintain roughli
ownership busi includ outright equiti
overli materi overal assess
think firm long-stand polici separ ceo
board chairman role help contribut
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
fiscal result put track exceed full-year
fiscal good start compani
post fiscal first-quart result exceed
consensu expect across board firm report
organ growth constant currenc
quarter well ahead manag outlook
start year result compani rais revenu
growth ep guidanc -- someth manag almost
never quarter worth perform
like take fair valu estim mid-single-
digit percentag result caution investor
assum mark new sustain growth rate
firm moatworthi busi appli steril
technolog remark quarter constant currenc
revenu growth surpass segment oper
margin expand nearli basi point last year
record much attribut improv
plant util medic devic oem continu
increas product volum increasingli choos
outsourc steril servic margin rather
invest expand capac intern manag
stepped-up capit invest program fiscal
aim build addit steril capac
global believ prove attract use
capit long term
remain busi also broadli outperform
expect consum sale healthcar
product life scienc expand high-single-digit
rate capit equip sale came stronger
anticip better revenu perform translat
basi point roughli basi point better
project
full-year forecast like increas modestli
result estim adjust ep year
consist manag rais guidanc rang
post strong finish fiscal initi
outlook ahead expect may
narrow-moat finish fiscal remark
quarter year updat roll
model like rais per share fair valu
estim mid-single-digit percentag posit
off-set higher-than-expect capit invest
program next sever year strength broad
base across four busi lay groundwork
solid expect come year fell
lower end manag outlook call
organ revenu growth adjust earn
growth roughli howev share trade
near time ep project think stock
remain expens side fair valu
segment report robust quarterli growth
appli steril technolog healthcar servic
segment continu outperform busi grew
revenu low doubl digit year year
contribut basi point companywid
announc invest initi put fiscal
capit expenditur well ahead million
estim manag intend invest roughli
million increment growth capit place total
capit expenditur budget near million bulk
spend alloc global capac addit
ast segment help support mid- high-single-
digit growth long term higher level
invest lower free cash flow forecast next
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
year midteen mid-cycle free cash flow margin
view ast competit advantag
franchis segment oper margin
eclips think
invest
manag long histori prudent capit deploy
consist exemplari stewardship rate
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
financi summari forecast
fiscal year end march
earn interest tax
return asset
return equiti
valuat summari forecast
equiti
pre-tax debt
weight averag capit
addit estim scenario avail download http //select morningstar com
equival
data tabl repres base-cas forecast compani report
currenc begin current year fair valu estim may differ
equiti valu per share shown due time valu money adjust case
probability-weight scenario analysi perform
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
fiscal year end march
good sold
depreci amort report separ
impair charg report separ
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
